Table 1.

Clinical and Laboratory Characteristics of Patients Positive for aPL and of SLE Patients Negative for aPL

aPL-Negative Patients (n = 18) aPL-Positive Patients (n = 18) P Value
Age (yrs) 
 Mean ± SD  37 ± 8  38 ± 11  NS  
 Range 23-50    17-53    
Male sex (n) (%)  1 (6) 2 (11)  NS  
Diabetes mellitus (n) (%) 3 (17)  4 (22)  NS  
Hypertension (n) (%) 4 (22)  5 (28)  NS  
Smoking (n) (%) 5 (28)  4 (22)  NS  
F1 + 2 (nmol/L) 
 Mean  1.02  1.83  .0001  
 SD  0.38  0.56 
IPF-III (pg/mg creatinine)  
 Median 135  242  .0001  
 Range  80-210  72-405   
IPF-VI (pg/mg creatinine) 
 Median  1,057  1,600  .006  
 Range  449-1,780  580-2,400 
aPL-Negative Patients (n = 18) aPL-Positive Patients (n = 18) P Value
Age (yrs) 
 Mean ± SD  37 ± 8  38 ± 11  NS  
 Range 23-50    17-53    
Male sex (n) (%)  1 (6) 2 (11)  NS  
Diabetes mellitus (n) (%) 3 (17)  4 (22)  NS  
Hypertension (n) (%) 4 (22)  5 (28)  NS  
Smoking (n) (%) 5 (28)  4 (22)  NS  
F1 + 2 (nmol/L) 
 Mean  1.02  1.83  .0001  
 SD  0.38  0.56 
IPF-III (pg/mg creatinine)  
 Median 135  242  .0001  
 Range  80-210  72-405   
IPF-VI (pg/mg creatinine) 
 Median  1,057  1,600  .006  
 Range  449-1,780  580-2,400 

Statistical analysis was performed by Mann-Whitney-U test.

Abbreviation: NS, not significant.

or Create an Account

Close Modal
Close Modal